When the list gets long enough that you stop counting
You could probably name six or seven of them. Maybe more.
You could probably name six or seven of them. Maybe more.
The one that made you gain thirty pounds. The one that flattened everything, good and bad. The one that worked for four months and then quietly stopped. The one your doctor was excited about.
Somewhere in there you started keeping a mental list, and somewhere after that you stopped bothering.
The appointments have a rhythm now. Your prescriber asks how you're doing. You say something honest but not too honest. They suggest adjusting the dose, or adding something, or trying a different class. You agree, because what else is there. You go home with a new prescription and a familiar feeling — not hope exactly, more like the memory of hope.
What this actually means
About a third of people with depression don't get adequate relief from oral antidepressants. That's not a small unlucky minority. It's a known limitation of how those medications work.
If you've tried two or more without adequate response, there's a clinical term for where you are: treatment-resistant depression. It sounds like a judgment. It isn't. It's a category that exists specifically because this is common enough to need one — and because treatments were developed for it.
You are not failing at treatment. The treatment has been failing you, and there are other mechanisms.
Why SPRAVATO® is a different conversation
SPRAVATO® is esketamine. It's FDA-approved for treatment-resistant depression, and it acts on a different system in the brain than the medications you've likely been cycling through. That's the whole reason it exists — for people the standard mechanism hasn't reached.
It's not a pill. You come to a certified center, self-administer a nasal spray under supervision, and stay for at least two hours of monitoring. It is a real commitment, and it has real risks, including a boxed warning you should read before deciding anything.
But it is genuinely a different approach, not another version of what you've already tried.
What to bring to the conversation
If you can, put together a rough list — which medications, roughly when, what happened. Approximate is fine. It matters both clinically and for insurance, since prior authorization usually requires documentation of prior trials.
Important Safety Information
BOXED WARNING: SPRAVATO® can cause sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. SPRAVATO® is only available through a restricted program called the SPRAVATO® REMS.
SPRAVATO® can cause sleepiness, fainting, dizziness, spinning sensation, anxiety, dissociation, and breathing problems. Patients must be monitored by a healthcare provider for at least 2 hours after each dose. There is a risk of abuse and misuse, which may lead to physical and psychological dependence. Antidepressant medicines may increase suicidal thoughts and actions in some people 24 years of age and younger. SPRAVATO® is not for use in children.
Do not take SPRAVATO® if you have aneurysmal vascular disease, an arteriovenous malformation, a history of bleeding in the brain, or an allergy to esketamine or ketamine.
Do not drive or operate machinery until the next day after a restful sleep.
The most common side effects include feeling disconnected from yourself, your thoughts, feelings and surroundings; dizziness; nausea; sleepiness; spinning sensation; numbness; anxiety; lack of energy; increased blood pressure; vomiting; feeling drunk; headache; and feeling very happy or excited. If these occur, they usually happen right after taking SPRAVATO® and go away the same day.
Neuro Wellness TMS Centers of America is a certified SPRAVATO® REMS treatment center. SPRAVATO® is only available at healthcare settings certified in the SPRAVATO® REMS program and must be self-administered under the supervision of a healthcare provider.
Please see the full Prescribing Information, including Boxed Warnings, and the Medication Guide, and discuss any questions with your healthcare provider.
SPRAVATO® is a registered trademark of Johnson & Johnson and its affiliates. Neuro Wellness TMS Centers of America is not affiliated with or endorsed by Johnson & Johnson.
Bring your list to the conversation
If you can, put together a rough list — which medications, roughly when, what happened. It matters both clinically and for insurance. Schedule a free phone consultation or call (954) 827-9793.